Oral Ondansetron versus Domperidone for Acute Gastroenteritis in Pediatric Emergency Departments: Multicenter Double

Federico Marchetti1, Maurizio Bonati2, Alessandra Maestro3

  • 1Department of Pediatrics, Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy.

Plos One
|November 24, 2016
PubMed

Insights

Ondansetron significantly reduced the need for intravenous rehydration in children with gastroenteritis compared to placebo or domperidone. This antiemetic facilitates oral rehydration success when initial attempts fail.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Pharmacology
  • Gastroenterology

Background:

  • Vomiting associated with acute gastroenteritis in children presents a clinical challenge.
  • The efficacy of antiemetics in managing pediatric gastroenteritis remains under investigation.
  • Oral rehydration is the primary treatment, but failure necessitates alternative strategies.

Purpose of the Study:

  • To compare the effectiveness of ondansetron, domperidone, and placebo in treating vomiting in children with acute gastroenteritis.
  • To evaluate the impact of these treatments on the need for intravenous or nasogastric rehydration.
  • To determine the optimal antiemetic strategy for children experiencing vomiting refractory to initial oral rehydration.

Main Methods:

  • A double-blind, randomized controlled trial involving children aged 1-6 years admitted for gastroenteritis.
  • Participants received a single oral dose of ondansetron, domperidone, or placebo after initial oral rehydration failure.
  • The primary outcome measured was the rate of subsequent nasogastric or intravenous rehydration.

Main Results:

  • Ondansetron use resulted in a >50% reduction in the need for intravenous rehydration compared to both placebo and domperidone.
  • 11.8% of children receiving ondansetron required intravenous rehydration versus 25.2% (domperidone) and 28.8% (placebo).
  • No significant differences in adverse events were observed across the treatment groups.

Conclusions:

  • A single oral dose of ondansetron is effective in reducing the need for intravenous rehydration in children with gastroenteritis who fail initial oral rehydration.
  • Ondansetron facilitates the success of oral rehydration and reduces persistent vomiting.
  • Domperidone demonstrated no significant benefit for symptomatic treatment of vomiting in this pediatric gastroenteritis cohort.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
759
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.6K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
695
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
515
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
796
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
660